Detalles de la búsqueda
1.
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature;
612(7941): 778-786, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36517593
2.
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol;
187: 80-84, 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735143
3.
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Gynecol Oncol;
186: 104-109, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640773
4.
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
Gynecol Oncol;
182: 141-147, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262237
5.
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
Int J Gynecol Cancer;
2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514101
6.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer;
34(4): 594-601, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296517
7.
Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Gynecol Oncol;
179: 152-157, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980770
8.
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol;
169: 118-124, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36565685
9.
Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
Gynecol Oncol;
168: 1-7, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334496
10.
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol;
179: 169-179, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992548
11.
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center study.
Gynecol Oncol;
170: 46-53, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621269
12.
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
Gynecol Oncol;
170: 93-101, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669327
13.
Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
Gynecol Oncol;
169: 85-90, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521353
14.
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trial.
Gynecol Oncol;
168: 100-106, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423444
15.
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma.
Gynecol Oncol;
174: 262-272, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245486
16.
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial.
Gynecol Oncol;
171: 23-30, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36804618
17.
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications.
Gynecol Oncol;
175: 163-168, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390597
18.
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol;
176: 69-75, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37454565
19.
Germline drivers of gynecologic carcinosarcomas.
Gynecol Oncol;
174: 34-41, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149903
20.
Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction.
AJR Am J Roentgenol;
221(6): 760-772, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37436033